文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

评估以色列普遍性乙型肝炎疫苗接种计划及产前乙型肝炎表面抗原筛查:2015-2016年真实世界研究结果

Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
PubMed 文献 · Vaccine · 2021-11-12

结果显示疫苗三剂覆盖率分别为94%、93%和89%,HBsAg阳性母亲所生婴儿出生剂次覆盖率达95%,成本效益比分别为1.24:1(含产前筛查)和4.15:1(不含产前筛查)。作者认为该疫苗接种计划在流行病学和经济上均合理。

要点

  • 2015-2016年以色列婴儿HBV疫苗第一、二、三剂覆盖率分别为94%、93%和89%。
  • HBsAg阳性母亲所生婴儿出生剂次覆盖率为95%,显著高于HBsAg阴性或未筛查母亲所生婴儿(p < 0.001)。
  • 产前HBsAg筛查覆盖97.7%的母亲,HBsAg阳性率为0.2%(124/71,107)。

核心结论

  • 作者认为以色列HBV疫苗接种计划在流行病学和经济上均合理。
  • HBsAg阳性母亲所生婴儿的高覆盖率反映对疫苗接种计划和产前筛查的良好依从性。
  • 移民母亲中较高的HBsAg阳性率提示该人群为HBV感染高风险人群。

研究设计与样本

  • 纳入2015-2016年出生的77,572名活产婴儿及其72,792名母亲。
  • 收集母亲年龄、族裔、出生国及孕期HBsAg状态,计算婴儿HBV疫苗接种覆盖率,并基于HBsAg阳性母亲HBV感染治疗实际费用进行成本效益分析。

主要发现

  • 71,107名(97.7%)母亲孕期接受HBV筛查,其中124名(0.2%)HBsAg阳性,共分娩132名婴儿。
  • 婴儿HBV疫苗第一、二、三剂覆盖率分别为94%、93%和89%。
  • HBsAg阳性母亲所生婴儿出生剂次覆盖率为95%,显著高于HBsAg阴性或未筛查母亲所生婴儿(p < 0.001)。
  • 以色列出生、前苏联出生和埃塞俄比亚出生母亲的HBsAg阳性率分别为0.1%、0.8%和5%(p < 0.001)。
  • HBsAg阳性与HBsAg阴性母亲之间未发现族裔差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Universal vaccination against hepatitis B virus (HBV) in infancy was implemented in Israel in 1992. This population-based study aimed to evaluate the coverage rate and cost-benefit of the HBV vaccination program among infants in Israel and the Hepatitis B surface antigen (HBsAg) status in their mothers. METHODS: Using the database of a health maintenance organization with 2 million members, we retrospectively identified, all the infants born in 2015-2016 and their mothers. Maternal data collected included age, ethnicity, country of birth and HBsAg status during pregnancy. HBV vaccination coverage among infants was calculated. A cost-benefit analysis of the HBV vaccination program was conducted based on the actual costs of HBV infection treatments in all HBsAg positive mothers. RESULTS: Our cohort included 72,792 mothers who gave birth to 77,572 live infants. A total of 71,107 (97.7%) mothers were screened for HBV during pregnancy, of them 124 (0.2%), who gave birth to 132 infants were HBsAg positive. HBV vaccination coverage rates were 94%, 93% and 89%, for the first, second and third dose, respectively. Birth dose coverage of 95% among infants born to HBsAg positive mothers was significantly higher compared to HBsAg negative or unscreened mothers (p < 0.001). The percentage of HBsAg positivity among mothers who were born in Israel, the Former Soviet Union or Ethiopia, were 0.1%, 0.8% and 5%, respectively (p < 0.001). Ethnic differences were not found between HBsAg positive and HBsAg negative mothers. Calculated benefit-to-cost ratios were 1.24:1 and 4.15:1, with and without antenatal HBsAg screening, respectively. CONCLUSIONS: The Israeli vaccination program against HBV infection is epidemiologically and economically justified. High coverage rates among infants born to HBsAg positive mothers reflect very good adherence to the vaccination program and antenatal screening. Higher HBsAg positivity rates among immigrant mothers identify a high-risk population for HBV infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Netanel C, Ben-Aharon O, Ben-Ari Z, et al. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016. Vaccine. 2021. PMID: 34782158. doi:10.1016/j.vaccine.2021.09.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。